IL6 and breast cancer: Given that the IL-6/JAK/STAT3 signaling axis promotes metastatic phenotypes of breast cancer, researchers have investigated the role of IL-6/JAK/STAT3 in breast cancer metastasis in vivo to identify key drivers and therapeutic interventions.